We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 44.14 | 0 | 01:00:00 |
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Dr Hal Barron
|
|
b)
|
Position/status
|
Non-Executive Director
|
|
c)
|
Initial
notification/amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GSK plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
|
|
b)
|
Nature
of the transaction
|
Acquisition of notional ADSs within Dr Barron's GSK Executive
Supplemental Savings Plan account following the reinvestment of
dividends
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
$42.160
|
2,773.2519
|
||
d)
|
Aggregatedinformation
|
N/A (single transaction)
|
|
Aggregated
volume
Price
|
|
||
e)
|
Date
of the transaction
|
2024-02-22
|
|
f)
|
Place
of the transaction
|
New York Stock Exchange (XNYS)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
Dr Hal Barron
|
|
b)
|
Position/status
|
Non-Executive Director
|
|
c)
|
Initial
notification/amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GSK plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
|
|
b)
|
Nature
of the transaction
|
Acquisition of ADSs within Dr Barron's GSK 401(k) plan account
following the reinvestment of dividends
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
$42.160
|
70
|
||
d)
|
Aggregatedinformation
|
N/A (single transaction)
|
|
Aggregated
volume
Price
|
|
||
e)
|
Date
of the transaction
|
2024-02-22
|
|
f)
|
Place
of the transaction
|
New York Stock Exchange (XNYS)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
a)
|
Name
|
James Ford
|
|
b)
|
Position/status
|
SVP and Group General Counsel, Legal and Compliance
|
|
c)
|
Initial
notification/amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
GSK plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
a)
|
Description
of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W2044
|
|
b)
|
Nature
of the transaction
|
Acquisition of notional ADSs within Mr Ford's GSK Executive
Supplemental Savings Plan account following the reinvestment of
dividends
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
$42.160
|
51.6032
|
||
d)
|
Aggregated
information
|
N/A (single transaction)
|
|
Aggregated
volume
Price
|
|
||
e)
|
Date
of the transaction
|
2024-02-22
|
|
f)
|
Place
of the transaction
|
New York Stock Exchange (XNYS)
|
|
GSK plc
|
|
(Registrant)
|
|
|
Date: February
26, 2024
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GSK plc
|
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions